VERTEX PHARMACEUTICALS INC / MA Remaining Share Repurchase Authorization
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Remaining Share Repurchase Authorization of $2.60 billion as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2026-08-04
- 2026-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $2.60B.
- 2026-03-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $3.00B.
- 2025-09-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $3.50B.
- 2025-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $4.60B.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2026-06-30 | $2.60B 10-Q · filed 2026-08-04 |
| 2026-03-31 | $3.00B 10-Q · filed 2026-05-05 |
| 2025-09-30 | $3.50B 10-Q · filed 2025-11-04 |
| 2025-06-30 | $4.60B 10-Q · filed 2025-08-05 |
| 2025-03-31 | $964.40M 10-Q · filed 2025-05-06 |
| 2024-09-30 | $1.80B 10-Q · filed 2024-11-05 |
| 2024-06-30 | $2.10B 10-Q · filed 2024-08-02 |
| 2024-03-31 | $2.40B 10-Q · filed 2024-05-07 |
| 2023-09-30 | $2.70B 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.80B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $2.90B 10-Q · filed 2023-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |